Crossmark

Paeonol protects against cisplatin-induced premature ovarian failure via anti-inflammatory and antioxidant activities: an integrated approach of network pharmacology, molecular dynamics simulation, and experimental validation

Crossref DOI link: https://doi.org/10.1007/s00210-025-04430-2

Published Online: 2025-07-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Xinyue

Han, Yan

Tang, Xinhui

Ren, Yun

Gao, Weiqi

Li, Yongai

Xue, Yuchen

Li, Xinghua

Suo, Yuping
Funding

Funding for this research was provided by:

Fundamental Research Program of Shanxi Province (No.202303021212366, No.202303021212367, No.202303021212376)
License Information

Text and Data Mining valid from 2025-07-24

Version of Record valid from 2025-07-24
More Information

Article History

Received: 24 April 2025

Accepted: 26 June 2025

First Online: 24 July 2025

Declarations

:

: The authors declare that they have no competing interest.

Document is current

Any future updates will be listed below